Your browser doesn't support javascript.
loading
Pancreatic sympathetic innervation disturbance in type 1 diabetes.
Li, Senlin; Yuan, Huimin; Yang, Keshan; Li, Qing; Xiang, Ming.
  • Li S; Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Yuan H; Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Yang K; Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Li Q; Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Xiang M; Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: xiangming@tjmu.edu.cn.
Clin Immunol ; 250: 109319, 2023 05.
Article en En | MEDLINE | ID: mdl-37024024
ABSTRACT
Pancreatic sympathetic innervation can directly affect the function of islet. The disorder of sympathetic innervation in islets during the occurrence of type 1 diabetes (T1D) has been reported to be controversial with the inducing factor unclarified. Several studies have uncovered the critical role that sympathetic signals play in controlling the local immune system. The survival and function of endocrine cells can be regulated by immune cell infiltration in islets. In the current review, we focused on the impact of sympathetic signals working on islets cell regulation, and discussed the potential factors that can induce the sympathetic innervation disorder in the islets. We also summarized the effect of interference with the islet sympathetic signals on the T1D occurrence. Overall, a comprehensive understanding of the regulatory effect of sympathetic signals on islet cells and local immune system could facilitate better strategies design to control inflammation and protect ß cells in T1D therapy.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Islotes Pancreáticos / Diabetes Mellitus Tipo 1 / Células Secretoras de Insulina Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Islotes Pancreáticos / Diabetes Mellitus Tipo 1 / Células Secretoras de Insulina Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article